Merck gets partial thumbs-down on Keytruda in lymphoma from NICE cost-effectiveness watchdogs 글 내용 전체보기
Pall Corporation And Celltheon Form Strategic Partnership For Biotherapeutics Development And Manufacturing With CELLTHEON SMART™ Expression Platform 글 내용 전체보기
Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Perfusion-Enabled Bioreactors 글 내용 전체보기